Figure 2

Prognosis after HSCT in the whole cohort. (A) Overall survival after HSCT was calculated using the Kaplan–Meier method. (B) Non-relapse mortality is shown treating relapse as a competing risk. (C) The cumulative incidence of relapse was calculated treating death without relapse as a competing risk.